Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (691-700 of 1,142) with videos related to

Pageof 115
Sort By:
Clinical Imaging|July 26, 2002
Magnetic resonance imaging of mesenrhombencephalitisJohn J Wasenko, Brian J Park, Burk Jubelt, et al.
Schizophrenia Research|September 12, 2002
Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorderDelbert G Robinson, Margaret G Woerner, Jose Ma J Alvir, et al.
Anesthesiology|February 26, 2000
Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg(-1) x min(-1)J A Lieberman, R B Weiskopf, S D Kelley, et al.
Immunity|July 1, 1996
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonistsD S Lyons, S A Lieberman, J Hampl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1994
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophreniaJ A Lieberman, J Alvir, S Geisler, et al.
European Journal of Cancer Care|July 19, 2019
Digital literacy linked to engagement and psychological benefits among breast cancer survivors in Internet-based peer support groupsStephen J Lepore, Maria A Rincon, Joanne S Buzaglo, et al.
The American Journal of the Medical Sciences|July 1, 1979
Treatment of Parkinson's disease with dopamine agonists: a reviewA Lieberman, A Neophytides, M Kupersmith, et al.
Archives of Physical Medicine and Rehabilitation|December 9, 2009
Wheelchair repairs, breakdown, and adverse consequences for people with traumatic spinal cord injuryLaura A McClure, Michael L Boninger, Michelle L Oyster, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
Human Psychopharmacology|August 19, 2007
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysisVincenzo De Luca, Daniel J Müller, Rudi Hwang, et al.
Pageof 115

Showing results (691-700 of 1,142) with videos related to

Sort By:
Pageof 115
Clinical Imaging|July 26, 2002
Magnetic resonance imaging of mesenrhombencephalitisJohn J Wasenko, Brian J Park, Burk Jubelt, et al.
Schizophrenia Research|September 12, 2002
Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorderDelbert G Robinson, Margaret G Woerner, Jose Ma J Alvir, et al.
Anesthesiology|February 26, 2000
Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg(-1) x min(-1)J A Lieberman, R B Weiskopf, S D Kelley, et al.
Immunity|July 1, 1996
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonistsD S Lyons, S A Lieberman, J Hampl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1994
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophreniaJ A Lieberman, J Alvir, S Geisler, et al.
European Journal of Cancer Care|July 19, 2019
Digital literacy linked to engagement and psychological benefits among breast cancer survivors in Internet-based peer support groupsStephen J Lepore, Maria A Rincon, Joanne S Buzaglo, et al.
The American Journal of the Medical Sciences|July 1, 1979
Treatment of Parkinson's disease with dopamine agonists: a reviewA Lieberman, A Neophytides, M Kupersmith, et al.
Archives of Physical Medicine and Rehabilitation|December 9, 2009
Wheelchair repairs, breakdown, and adverse consequences for people with traumatic spinal cord injuryLaura A McClure, Michael L Boninger, Michelle L Oyster, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
Human Psychopharmacology|August 19, 2007
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysisVincenzo De Luca, Daniel J Müller, Rudi Hwang, et al.
Pageof 115